As shown in Supplementary Figures 3, 4, combined with the protein targets screened in the previous network pharmacology, we suppose miR-145 suppresses tumorigenesis and metastasis of the colorectal cancer cells by inhibiting the expression of EGFR. This evidence concerns the gene EGFR and colorectal cancer.